ENO2 and cancer: For example, Wang et al. [7] revealed that nuclear hepatoma-derived growth factor could upregulate the expression of solute carrier family 2 (facilitated glucose transporter), member 4 and ENO2, responsible for the activation of glycolysis in gastric cancer cells, which might facilitate the growth of cancer cells and metastasis processes.